Rectal Wall Thickening
Rectal wall thickening is a radiology report finding rather than a diagnosis: it describes a rectal wall that appears thicker than expected on CT or MRI. Like similar findings elsewhere in the digestive tract, one of the most common explanations is technical rather than pathological—a rectum that was collapsed or incompletely distended when the images were acquired can look falsely thickened. Genuine causes span inflammation, infection, radiation change, and cancer. Because the appearance alone frequently cannot separate these, and because the rectum is directly accessible to examination and endoscopy, this is one finding where the next step is usually straightforward: direct inspection resolves what imaging cannot.
What is it?
The rectum is the final section of the large intestine, roughly 12 to 15 centimetres long, sitting in the pelvis between the sigmoid colon and the anal canal. Its wall has the same basic layers as the rest of the bowel—an inner mucosa, a submucosa, a muscular layer, and an outer covering—though the upper rectum is partly covered by peritoneum while the lower rectum lies entirely outside it, surrounded instead by the fatty mesorectum. This anatomical detail becomes important in cancer staging.
The rectum functions as a reservoir, storing stool until it is convenient to pass. It is therefore designed to be collapsed much of the time and to distend when filled. A wall measured while the rectum is empty and contracted will appear considerably thicker than the same wall measured when distended, in exactly the same way as elsewhere in the digestive tract.
This is the first thing to understand about the finding. Rectal wall thickening is a description of an appearance rather than a diagnosis, and routine abdominal CT is a relatively poor test for the rectum: it is usually performed without rectal contrast or air, often with the rectum empty or containing stool, and the resulting apparent thickening is frequently an artefact of technique rather than a real abnormality. Radiologists are aware of this, which is why reports often include qualifying language such as likely related to underdistension, non-specific, or correlate clinically and consider direct visualisation.
When thickening is genuine, several features help narrow the cause. Distribution matters: circumferential thickening involving a length of rectum suggests inflammation, infection, or radiation change, while focal, asymmetric, or shouldered thickening raises concern for tumour. Layering matters: a preserved stratified appearance with a distinct enhancing inner lining and a lower-density submucosal layer—sometimes described as a target sign—suggests inflammation or oedema, while homogeneous loss of that layering is more concerning. Surrounding tissue matters: perirectal fat stranding, fluid, proliferation of surrounding fat, enlarged lymph nodes, fistulous tracks, and abscess all shift the assessment substantially.
The causes fall into several groups.
Inflammatory causes are the most frequent genuine explanation. Ulcerative colitis characteristically involves the rectum and extends proximally in a continuous fashion, producing symmetric circumferential thickening, often with proliferation of surrounding fat in longstanding disease. Crohn’s disease can affect the rectum, typically with more asymmetric involvement and a greater tendency to produce fistulas and abscesses in the perianal region. Diverticulitis of the distal sigmoid can extend inflammation into the upper rectum.
Infectious proctitis is an important and sometimes overlooked category. Sexually transmitted infections including gonorrhoea, chlamydia—particularly the lymphogranuloma venereum serovars—syphilis, and herpes simplex virus cause proctitis, most commonly in men who have sex with men and in people with HIV. Lymphogranuloma venereum in particular can produce marked thickening, deep ulceration, and perirectal lymphadenopathy that closely mimics both Crohn’s disease and rectal cancer on imaging, and misdiagnosis is well documented. Other infections including Clostridioides difficile, cytomegalovirus in immunocompromised patients, and various bacterial and parasitic causes also occur.
Radiation proctitis follows radiotherapy to the pelvis for prostate, cervical, endometrial, bladder, or rectal cancer. Acute changes occur during or shortly after treatment, while chronic radiation proctitis develops months to years later and produces wall thickening, characteristic submucosal changes, fragile telangiectatic vessels that bleed readily, and sometimes stricture or fistula. A history of pelvic radiotherapy, even years earlier, substantially reframes the interpretation of rectal thickening.
Rectal cancer is the concern that drives most further evaluation. Adenocarcinoma is by far the most common type and typically produces focal, irregular, asymmetric thickening, often with loss of the layered appearance, sometimes with narrowing of the lumen and enlarged perirectal nodes. Less commonly, lymphoma, neuroendocrine tumours, gastrointestinal stromal tumours, anal canal cancers extending upward, and metastatic or peritoneal disease involving the rectum produce thickening. Prostate cancer invading the rectum posteriorly is a recognised though uncommon cause.
Vascular and ischaemic causes include ischaemic proctitis, which is relatively uncommon because the rectum has a rich dual blood supply, and rectal varices in portal hypertension, which are distinct from haemorrhoids and can produce apparent wall abnormality.
Other causes include solitary rectal ulcer syndrome, a condition related to abnormal defecation dynamics and chronic straining that produces focal thickening—usually on the anterior wall—which can closely mimic cancer on imaging and even on initial biopsy, and which is treated with bowel habit modification and pelvic floor therapy rather than surgery. Rectal prolapse and intussusception of the rectum produce similar changes. Endometriosis involving the rectosigmoid produces nodular thickening, characteristically on the anterior wall, in women of reproductive age with cyclical symptoms. Stercoral proctitis results from pressure of impacted stool. Postoperative and post-procedural change, including after haemorrhoid treatment or rectal surgery, can also produce thickening.
Symptoms depend on the cause and are absent in a significant proportion, particularly when the finding is incidental.
When present, rectal bleeding is the most common and the most important symptom. It may be bright red on the stool surface or on wiping, mixed with mucus, or darker. Because haemorrhoids are extremely common, rectal bleeding is often attributed to them, and this attribution without examination is one of the more consequential errors in this area—haemorrhoids and rectal cancer frequently coexist, and bleeding should be evaluated rather than assumed benign.
Tenesmus—a persistent sensation of needing to pass stool despite the rectum being empty—is characteristic of rectal pathology and reflects an irritated or infiltrated rectal wall. Mucus discharge is common in proctitis. Change in bowel habit, narrowed stool calibre, urgency, incontinence, and rectal or pelvic pain all occur. Weight loss, fatigue, and iron deficiency anaemia suggest more significant disease. Fever, severe pain, and systemic illness suggest infection or abscess.
Evaluation follows a fairly clear path, and this is one of the areas where the next step after an imaging finding is unusually well defined.
Digital rectal examination is simple, immediate, and informative, and can identify a mass, ulceration, tenderness, blood, or a stricture within reach of the examining finger. It is frequently omitted and should not be.
Endoscopy is the decisive test. Flexible sigmoidoscopy or colonoscopy allows direct inspection of the rectal lining and targeted biopsy, and distinguishes between the causes that imaging cannot. In most patients with genuine rectal wall thickening on CT and any symptoms, endoscopy rather than repeat imaging is the appropriate next step. Colonoscopy also assesses the remainder of the colon, which matters when inflammatory bowel disease or a synchronous lesion is a possibility.
MRI of the pelvis is the reference standard for characterising rectal pathology and is essential for staging rectal cancer. It defines the depth of invasion through the wall, the relationship to the mesorectal fascia—the plane along which surgery is performed—the involvement of lymph nodes, and the presence of extramural vascular invasion. These details directly determine whether chemoradiotherapy is given before surgery and what operation is appropriate. MRI also characterises fistulas, abscesses, and endometriotic deposits well.
Endorectal ultrasound assesses the depth of early tumours with high resolution and is used when distinguishing superficial from deeper invasion will change management.
CT of the chest, abdomen, and pelvis assesses for distant spread once cancer is confirmed.
Blood tests support the assessment: complete blood count and iron studies for anaemia, inflammatory markers, kidney and liver function, and CEA as a baseline in confirmed cancer. Stool studies including culture, C. difficile testing, and faecal calprotectin help where infection or inflammatory bowel disease is suspected, and testing for sexually transmitted infections is appropriate when the clinical context suggests infectious proctitis.
Important to Know
Because rectal wall thickening is an imaging description rather than a diagnosis, the appropriate response is proportionate assessment. The distinguishing feature of this particular finding is that the answer is usually easy to obtain: the rectum can be examined directly, and endoscopy resolves in minutes what imaging may leave uncertain. Care is typically coordinated by primary care clinicians and gastroenterologists, with colorectal surgery and oncology involved when cancer is confirmed.
Mild or possible rectal wall thickening reported in someone with no symptoms, no bleeding, no anaemia, and no other abnormal findings frequently reflects a rectum that was simply collapsed during the scan. Reports that already attribute the appearance to underdistension are describing exactly this. The right step is to discuss the finding with the clinician who ordered the scan, who can weigh it against symptoms and history the report does not capture.
That said, the threshold for proceeding to endoscopy is deliberately lower here than for similar findings elsewhere, for two reasons: the test is straightforward and low risk, and the condition that must not be missed—rectal cancer—is common, curable when caught early, and often produces few symptoms initially. Any rectal bleeding, change in bowel habit, tenesmus, weight loss, or unexplained iron deficiency accompanying the finding warrants endoscopic evaluation.
A specific point deserves emphasis. Rectal bleeding attributed to haemorrhoids without examination is a recognised route to delayed cancer diagnosis. Haemorrhoids are extremely common and frequently coexist with other pathology, so their presence does not explain away bleeding. This is particularly important in younger adults, in whom rectal cancer incidence has been rising and in whom symptoms are more likely to be attributed to benign causes.
Treatment depends entirely on the diagnosis. Infectious proctitis is treated with directed antimicrobial therapy, and where a sexually transmitted infection is identified, treatment includes appropriate regimens, testing for co-infections including HIV, and partner notification. Lymphogranuloma venereum requires an extended antibiotic course rather than standard chlamydia treatment, which is one reason establishing the specific organism matters.
Inflammatory bowel disease involving the rectum often responds well to topical therapy, since medication delivered directly by suppository or enema reaches the affected area at high concentration. Mesalamine preparations, topical corticosteroids, and systemic therapies including immunomodulators and biologic agents are used according to severity and extent.
Radiation proctitis is managed conservatively where possible, with topical treatments including sucralfate enemas and, for persistent bleeding from fragile vessels, endoscopic argon plasma coagulation, which is effective and repeatable. Hyperbaric oxygen therapy is used in selected refractory cases. Surgery is avoided where possible because operating on irradiated tissue carries elevated risk of poor healing.
Solitary rectal ulcer syndrome deserves particular mention because it is frequently misdiagnosed. It arises from abnormal defecation dynamics and chronic straining rather than from ulcerative or malignant disease, and both imaging and initial biopsy can suggest cancer. Treatment centres on stopping straining, optimising stool consistency, and pelvic floor physiotherapy with biofeedback, with surgery reserved for a small minority.
Rectal cancer treatment is stage-dependent and has evolved considerably. Very early tumours may be removed locally through transanal techniques. Most others are treated with total mesorectal excision, an operation that removes the rectum along with its surrounding fatty envelope intact, which markedly reduced local recurrence when it became standard. Chemoradiotherapy before surgery is used for locally advanced disease, and total neoadjuvant therapy—giving both chemotherapy and chemoradiotherapy before surgery—has become common. A significant development is that some patients achieve a complete clinical response to this treatment and may be managed with careful surveillance rather than surgery, an approach known as watch and wait, which avoids permanent stoma in selected patients. Mismatch repair deficient rectal cancers can respond dramatically to immunotherapy, and this is an area of rapid change.
Follow-up depends on the diagnosis, ranging from none for a benign explanation, to surveillance colonoscopy in inflammatory bowel disease, to structured oncologic monitoring after cancer treatment.
Care is typically coordinated by primary care and gastroenterology, with colorectal surgery, oncology, radiology, sexual health, and pelvic floor services involved as needed. Imaging, endoscopic, laboratory, and clinical findings are interpreted alongside the patient’s symptoms, examination, sexual history, radiation history, and broader clinical context rather than in isolation.
Patient education plays an important role. Understanding that rectal wall thickening is a description rather than a diagnosis, that a collapsed rectum is a common explanation, that endoscopy rather than repeat scanning is usually the deciding test, that rectal bleeding should never be assumed to be haemorrhoids without examination, and which symptoms genuinely change the picture all contribute to appropriate care and prevent both unnecessary worry and dangerous reassurance.
Red flag symptoms include rectal bleeding of any kind, particularly when persistent, mixed with stool, or occurring without pain; a persistent sensation of incomplete emptying or of needing to pass stool when the rectum is empty; change in bowel habit lasting more than a few weeks; narrowing of stool calibre; unintentional weight loss; fatigue or breathlessness suggesting anaemia; persistent rectal or pelvic pain; new incontinence; passage of air or stool through the vagina, suggesting a fistula; and fever with severe rectal pain suggesting abscess. These warrant prompt medical evaluation and generally direct examination and endoscopy.